{
  "@context": {
    "schema": "https://schema.org/",
    "fabio": "http://purl.org/spar/fabio/",
    "cito": "http://purl.org/spar/cito/",
    "dcterms": "http://purl.org/dc/terms/",
    "foaf": "http://xmlns.com/foaf/0.1/",
    "bibo": "http://purl.org/ontology/bibo/",
    "go": "http://purl.obolibrary.org/obo/GO_",
    "doid": "http://purl.org/obo/DOID_",
    "chebi": "http://purl.org/obo/CHEBI_",
    "atc": "http://purl.org/obo/ATC_",
    "pw": "http://purl.org/obo/PW_",
    "eco": "http://purl.org/obo/ECO_",
    "mondo": "http://purl.org/obo/MONDO_",
    "comptox": "https://comptox.epa.gov/",
    "mesh": "http://id.nlm.nih.gov/mesh/"
  },
  "@id": "https://doi.org/10.5551/jat.63507",
  "@type": "bibo:AcademicArticle",
  "dcterms:title": "Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial",
  "dcterms:creator": [
    {
      "@id": "https://orcid.org/0000-0001-2345-6789",
      "@type": "foaf:Person",
      "foaf:name": "Yasuhiro Nakano"
    },
    {
      "@id": "https://orcid.org/0000-0002-3456-7890",
      "@type": "foaf:Person",
      "foaf:name": "Mitsutaka Yamamoto"
    },
    {
      "@id": "https://orcid.org/0000-0003-4567-8901",
      "@type": "foaf:Person",
      "foaf:name": "Tetsuya Matoba"
    }
  ],
  "dcterms:abstract": "This study evaluates the impact of ezetimibe in combination with statin therapy on coronary plaque burden and explores the relationship with serum oxysterol levels.",
  "schema:datePublished": "2022-12-01",
  "schema:keywords": [
    "Ezetimibe",
    "Statin",
    "Oxysterols",
    "Coronary plaque",
    "Intravascular ultrasound"
  ],
  "fabio:hasPublicationVenue": {
    "@id": "http://doi.org/10.5551/jat.63507",
    "@type": "fabio:Journal",
    "schema:name": "Journal of Atherosclerosis and Thrombosis"
  },
  "fabio:hasPart": [
    {
      "@id": "section1",
      "@type": "fabio:Section",
      "dcterms:title": "Introduction",
      "fabio:hasContent": "Despite major advances in cardiovascular science, coronary artery disease (CAD) remains a leading cause of mortality."
    },
    {
      "@id": "section2",
      "@type": "fabio:Section",
      "dcterms:title": "Methods",
      "fabio:hasContent": "We conducted a prospective randomized, open, blinded-endpoint trial among patients with CAD receiving stenting."
    }
  ],
  "cito:cites": [
    {
      "@id": "https://doi.org/10.1001/jama.2015.8445",
      "@type": "bibo:AcademicArticle",
      "dcterms:title": "Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes",
      "bibo:doi": "10.1001/jama.2015.8445"
    },
    {
      "@id": "https://doi.org/10.1056/NEJMoa1512489",
      "@type": "bibo:AcademicArticle",
      "dcterms:title": "Effect of very high-intensity statin therapy on regression of coronary atherosclerosis",
      "bibo:doi": "10.1056/NEJMoa1512489"
    }
  ],
  "cito:discusses": [
    {
      "@id": "chebi:15377",
      "schema:name": "Water"
    },
    {
      "@id": "doid:14330",
      "schema:name": "Lung Cancer"
    },
    {
      "@id": "go:0008150",
      "schema:name": "Biological Process"
    }
  ]
}